Patent Application
App. No. 17/834,000
USE OF AMISULPRIDE AS AN ANTI-EMETIC
Loading inventors, assignments & file history…
Abstract
Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.
Claims (2)
1 . A pharmaceutical composition comprising amisulpride in an amount of less than 50 mg per dose, and a pharmaceutically acceptable carrier.
2 . A method for the prevention and/or treatment of post-operative nausea and vomiting, comprising administering amisulpride at a dose of less than 50 mg to a subject in need thereof.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 4, 2026
From: ACACIA PHARMA LIMITED; ACACIA PHARMA, INC.; EAGLE PHARMACEUTICALS, INC.
To: LXO IRELAND DESIGNATED ACTIVITY COMPANY; LXO US, INC.
Reel/Frame 073967/0303 →
RELEASE OF SECURITY INTEREST
Recorded Apr 1, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ACACIA PHARMA LIMITED
Reel/Frame 070698/0351 →
SECURITY INTEREST
Recorded Apr 28, 2023
From: ACACIA PHARMA LIMITED
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 063476/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 7, 2022
From: GILBERT, JULIAN CLIVE; GRISTWOOD, ROBERT WILLIAM; COOPER, NICOLA; FOX, GABRIEL
To: ACACIA PHARMA LIMITED
Reel/Frame 060120/0492 →